Literature DB >> 8140489

Age and clinical immunity to infections with Chlamydia trachomatis.

J N Arno1, B P Katz, R McBride, G A Carty, B E Batteiger, V A Caine, R B Jones.   

Abstract

BACKGROUND AND OBJECTIVES: The prevalence of chlamydial infection decreases with age possibly in part because of increasing immunity. GOAL OF THIS STUDY: To determine whether increased age is an independent predictor of decreased chlamydial infection and whether chlamydia-specific antibody titer and blastogenesis increase with age. STUDY
DESIGN: Data from all patients cultured for Chlamydia trachomatis between January 1984 and August 1989 were examined and multiple logistic regression models were used to identify the independent predictors of culture positivity. Antichlamydial antibody titer and chlamydia-specific blastogenesis were examined for a subset of patients for correlation with age.
RESULTS: Young age was found to be predictive of chlamydial infection independent of all factors examined in men and women. Antibody titers had no relation to age (n = 245) whereas the level of blastogenesis correlated only weakly with age (n = 155).
CONCLUSIONS: Assays of systemic immunity do not reflect the protection from chlamydial infection associated with age.

Entities:  

Mesh:

Year:  1994        PMID: 8140489     DOI: 10.1097/00007435-199401000-00010

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  12 in total

Review 1.  Human and Pathogen Factors Associated with Chlamydia trachomatis-Related Infertility in Women.

Authors:  S Menon; P Timms; J A Allan; K Alexander; L Rombauts; P Horner; M Keltz; J Hocking; W M Huston
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

2.  Identification of Chlamydia trachomatis Antigens Recognized by T Cells From Highly Exposed Women Who Limit or Resist Genital Tract Infection.

Authors:  Ali N Russell; Xiaojing Zheng; Catherine M O'Connell; Harold C Wiesenfeld; Sharon L Hillier; Brandie D Taylor; Michelle D Picard; Jessica B Flechtner; Wujuan Zhong; Lauren C Frazer; Toni Darville
Journal:  J Infect Dis       Date:  2016-10-12       Impact factor: 5.226

Review 3.  Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies.

Authors:  Byron E Batteiger; Fujie Xu; Robert E Johnson; Michael L Rekart
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

4.  Fluorometric high-throughput assay for measuring chlamydial neutralizing antibody.

Authors:  Timothy Southern; Leah Bess; Jillian Harmon; Lacey Taylor; Harlan Caldwell
Journal:  Clin Vaccine Immunol       Date:  2012-09-26

5.  Frequency of Chlamydia trachomatis-specific T cell interferon-γ and interleukin-17 responses in CD4-enriched peripheral blood mononuclear cells of sexually active adolescent females.

Authors:  Romina Barral; Ruchi Desai; Xiaojing Zheng; Lauren C Frazer; Gina S Sucato; Catherine L Haggerty; Catherine M O'Connell; Matthew A Zurenski; Toni Darville
Journal:  J Reprod Immunol       Date:  2014-02-01       Impact factor: 4.054

6.  Screening for Chlamydia trachomatis. New methods are needed to assess the burden of illness from chlamydia.

Authors:  I Simms; G Hughes; M Catchpole
Journal:  BMJ       Date:  1998-09-05

7.  B Cell Presentation of Chlamydia Antigen Selects Out Protective CD4γ13 T Cells: Implications for Genital Tract Tissue-Resident Memory Lymphocyte Clusters.

Authors:  Raymond M Johnson; Hong Yu; Norma Olivares Strank; Karuna Karunakaran; Ying Zhu; Robert C Brunham
Journal:  Infect Immun       Date:  2018-01-22       Impact factor: 3.441

8.  Optimizing strategies for population-based chlamydia infection screening among young women: an age-structured system dynamics approach.

Authors:  Yu Teng; Nan Kong; Wanzhu Tu
Journal:  BMC Public Health       Date:  2015-07-11       Impact factor: 3.295

9.  Estimating age-dependent per-encounter chlamydia trachomatis acquisition risk via a Markov-based state-transition model.

Authors:  Yu Teng; Nan Kong; Wanzhu Tu
Journal:  J Clin Bioinforma       Date:  2014-04-25

10.  Cellular Basis for the Enhanced Efficacy of the Fms-Like Tyrosine Kinase 3 Ligand (FL) Adjuvanted VCG-Based Chlamydia abortus Vaccine.

Authors:  Shakyra Richardson; Fnu Medhavi; Tayhlor Tanner; Stephanie Lundy; Yusuf Omosun; Joseph U Igietseme; Darin Carroll; Francis O Eko
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.